- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Biohaven Pharma Hldgs (NYSE:BHVN), Quotes and News Summary
Biohaven Pharma Hldgs (NYSE: BHVN)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-08 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -2.530 | -1.620 | 0.9100 | ||||
| REV | 181.110M | 318.850M | 137.740M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Biohaven Pharma Hldgs Questions & Answers
You can purchase shares of Biohaven Pharma Hldgs (NYSE: BHVN) through any online brokerage.
Other companies in Biohaven Pharma Hldgs’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Ionis Pharmaceuticals (NASDAQ:IONS).
The latest price target for Biohaven Pharma Hldgs (NYSE: BHVN) was reported by HC Wainwright & Co. on Wednesday, May 11, 2022. The analyst firm set a price target for 0.00 expecting BHVN to fall to within 12 months (a possible -100.00% downside). 21 analyst firms have reported ratings in the last year.
The stock price for Biohaven Pharma Hldgs (NYSE: BHVN) is $140.46 last updated May 16, 2022, 8:00 PM UTC.
There are no upcoming dividends for Biohaven Pharma Hldgs.
Biohaven Pharma Hldgs’s Q2 earnings are confirmed for Monday, August 8, 2022.
There is no upcoming split for Biohaven Pharma Hldgs.
Biohaven Pharma Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.